Co-morbidity and drug treatment in Alzheimer's disease. A cross sectional study of participants in the Dementia Study in Northern Norway
Open Access
- 4 October 2011
- journal article
- research article
- Published by Springer Nature in BMC Geriatrics
- Vol. 11 (1) , 58
Abstract
Inappropriate medical treatment of co-morbidities in Alzheimer's disease (AD) is an increasing concern in geriatric medicine. The objective of this study was to compare current drug use related to co-morbidity between individuals with a recent diagnosis of AD and a cognitively healthy control group in a population based clinical trial in Northern Norway.Keywords
This publication has 48 references indexed in Scilit:
- Cardiovascular risk and memory in non-demented elderly womenNeurobiology of Aging, 2010
- Daily Medication Use in Nursing Home Residents with Advanced DementiaJournal of the American Geriatrics Society, 2010
- Recruitment methods in Alzheimer's disease research: general practice versus population based screening by mailBMC Medical Research Methodology, 2010
- Change in Blood Pressure and Incident DementiaHypertension, 2009
- The cognitive impact of anticholinergics: A clinical reviewClinical Interventions in Aging, 2009
- Prevalence of comorbidity of chronic diseases in AustraliaBMC Public Health, 2008
- Prevalence of stress, anxiety and depression in with Alzheimer caregiversHealth and Quality of Life Outcomes, 2008
- Prevalence of Dementia in the United States: The Aging, Demographics, and Memory StudyNeuroepidemiology, 2007
- The Neuropsychiatric InventoryNeurology, 1994
- Comparison of Two Cognitive Rating Scales in Medically Ill PatientsThe International Journal of Psychiatry in Medicine, 1988